Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Feb 3;222(2):e20240625.
doi: 10.1084/jem.20240625. Epub 2024 Dec 31.

The phospholipid kinase PIKFYVE is essential for Th17 differentiation

Douglas S Prado  1   2 , Richard T Cattley  1   2 , Andreza B Sonego  1   2 , Parth Sutariya  1   2 , Shuxian Wu  1 , Mijoon Lee  3 , William C Boggess  3 , Mark J Shlomchik  1 , William F Hawse  1   2
Affiliations

The phospholipid kinase PIKFYVE is essential for Th17 differentiation

Douglas S Prado et al. J Exp Med. .

Abstract

T helper 17 (Th17) cells are effector cells that mediate inflammatory responses to bacterial and fungal pathogens. While the cytokine signaling inputs required to generate Th17s are established, less is known about intracellular pathways that drive Th17 differentiation. Our previously published phosphoproteomic screen identifies that PIKFYVE, a lipid kinase that generates the phosphatidylinositol PtdIns(3,5)P2, is activated during Th17 differentiation. Herein, we discovered that PIKFYVE regulates kinase and transcription factor networks to promote Th17 differentiation. As a specific example, PtdIns(3,5)P2 directly stimulates mTORC1 kinase activity to promote cell division and differentiation pathways. Furthermore, PIKFYVE promotes STAT3 phosphorylation, which is required for Th17 differentiation. Chemical inhibition or CD4-specific deletion of PIKFYVE reduces Th17 differentiation and autoimmune pathology in the experimental autoimmune encephalomyelitis murine model of multiple sclerosis. Our findings identify molecular mechanisms by which PIKFYVE promotes Th17 differentiation and suggest that PIKFYVE is a potential therapeutic target in Th17-driven autoimmune diseases.

PubMed Disclaimer

Conflict of interest statement

Disclosures: The authors declare no competing interests exist.

References

    1. Balla, T. 2013. Phosphoinositides: Tiny lipids with giant impact on cell regulation. Physiol. Rev. 93:1019–1137. 10.1152/physrev.00028.2012 - DOI - PMC - PubMed
    1. Baranov, M.V., Bianchi F., Schirmacher A., van Aart M.A.C., Maassen S., Muntjewerff E.M., Dingjan I., Ter Beest M., Verdoes M., Keyser S.G.L., et al. . 2019. The phosphoinositide kinase PIKfyve promotes cathepsin-S-mediated major histocompatibility complex class II antigen presentation. iScience. 11:160–177. 10.1016/j.isci.2018.12.015 - DOI - PMC - PubMed
    1. Cattley, R.T., Lee M., Boggess W.C., and Hawse W.F.. 2020. Transforming growth factor β (TGF-β) receptor signaling regulates kinase networks and phosphatidylinositol metabolism during T-cell activation. J. Biol. Chem. 295:8236–8251. 10.1074/jbc.RA120.012572 - DOI - PMC - PubMed
    1. Chen, Z., Laurence A., Kanno Y., Pacher-Zavisin M., Zhu B.M., Tato C., Yoshimura A., Hennighausen L., and O’Shea J.J.. 2006. Selective regulatory function of Socs3 in the formation of IL-17-secreting T cells. Proc. Natl. Acad. Sci. USA. 103:8137–8142. 10.1073/pnas.0600666103 - DOI - PMC - PubMed
    1. Codarri, L., Gyülvészi G., Tosevski V., Hesske L., Fontana A., Magnenat L., Suter T., and Becher B.. 2011. RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation. Nat. Immunol. 12:560–567. 10.1038/ni.2027 - DOI - PubMed

MeSH terms

Substances

LinkOut - more resources